Segment disclosures

Company overview

CELLULAR DYNAMICS INTERNATIONAL, INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

5 dimension combinations 60 retained observations 8 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Icell Cardiomyocytes

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=celdynp:IcellCardiomyocytesMember
PeriodValueUnitFiledEvidence
2014-01-01 – 2014-12-313175000 USD20150305Open filing evidence
2013-01-01 – 2013-12-314787000 USD20150305Open filing evidence
2013-07-01 – 2013-09-301026000 USD20131112Open filing evidence
2013-01-01 – 2013-09-303369000 USD20131112Open filing evidence
2013-04-01 – 2013-06-301228000 USD20130829Open filing evidence
2013-01-01 – 2013-06-302343000 USD20130829Open filing evidence
2012-01-01 – 2012-12-312610000 USD20150305Open filing evidence
2012-07-01 – 2012-09-30529000 USD20131112Open filing evidence
2012-01-01 – 2012-09-301583000 USD20131112Open filing evidence
2012-04-01 – 2012-06-30585000 USD20130829Open filing evidence
2012-01-01 – 2012-06-301054000 USD20130829Open filing evidence
2011-01-01 – 2011-12-311350000 USD20140311Open filing evidence

Icell Neurons

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=celdynp:IcellNeuronsMember
PeriodValueUnitFiledEvidence
2014-01-01 – 2014-12-313317000 USD20150305Open filing evidence
2013-01-01 – 2013-12-312428000 USD20150305Open filing evidence
2013-07-01 – 2013-09-30648000 USD20131112Open filing evidence
2013-01-01 – 2013-09-301624000 USD20131112Open filing evidence
2013-04-01 – 2013-06-30418000 USD20130829Open filing evidence
2013-01-01 – 2013-06-30976000 USD20130829Open filing evidence
2012-01-01 – 2012-12-312256000 USD20150305Open filing evidence
2012-07-01 – 2012-09-30483000 USD20131112Open filing evidence
2012-01-01 – 2012-09-301169000 USD20131112Open filing evidence
2012-04-01 – 2012-06-30547000 USD20130829Open filing evidence
2012-01-01 – 2012-06-30686000 USD20130829Open filing evidence
2011-01-01 – 2011-12-3145000 USD20140311Open filing evidence

My Cell

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=celdynp:MyCellMember
PeriodValueUnitFiledEvidence
2014-01-01 – 2014-12-31857000 USD20150305Open filing evidence
2013-01-01 – 2013-12-31222000 USD20150305Open filing evidence
2013-07-01 – 2013-09-300 USD20131112Open filing evidence
2013-01-01 – 2013-09-30170000 USD20131112Open filing evidence
2013-04-01 – 2013-06-30170000 USD20130829Open filing evidence
2013-01-01 – 2013-06-30170000 USD20130829Open filing evidence
2012-01-01 – 2012-12-310 USD20150305Open filing evidence
2012-07-01 – 2012-09-300 USD20131112Open filing evidence
2012-01-01 – 2012-09-300 USD20131112Open filing evidence
2012-04-01 – 2012-06-300 USD20130829Open filing evidence
2012-01-01 – 2012-06-300 USD20130829Open filing evidence
2011-01-01 – 2011-12-310 USD20140311Open filing evidence

Operating Segments And Other Domain

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=celdynp:OperatingSegmentsAndOtherDomain
PeriodValueUnitFiledEvidence
2014-01-01 – 2014-12-318077000 USD20150305Open filing evidence
2013-01-01 – 2013-12-317998000 USD20150305Open filing evidence
2013-07-01 – 2013-09-301793000 USD20131112Open filing evidence
2013-01-01 – 2013-09-305516000 USD20131112Open filing evidence
2013-04-01 – 2013-06-301969000 USD20130829Open filing evidence
2013-01-01 – 2013-06-303723000 USD20130829Open filing evidence
2012-01-01 – 2012-12-315178000 USD20150305Open filing evidence
2012-07-01 – 2012-09-301075000 USD20131112Open filing evidence
2012-01-01 – 2012-09-302892000 USD20131112Open filing evidence
2012-04-01 – 2012-06-301174000 USD20130829Open filing evidence
2012-01-01 – 2012-06-301817000 USD20130829Open filing evidence
2011-01-01 – 2011-12-311460000 USD20140311Open filing evidence

All Other Segments

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember
PeriodValueUnitFiledEvidence
2014-01-01 – 2014-12-31728000 USD20150305Open filing evidence
2013-01-01 – 2013-12-31561000 USD20150305Open filing evidence
2013-07-01 – 2013-09-30119000 USD20131112Open filing evidence
2013-01-01 – 2013-09-30353000 USD20131112Open filing evidence
2013-04-01 – 2013-06-30153000 USD20130829Open filing evidence
2013-01-01 – 2013-06-30234000 USD20130829Open filing evidence
2012-01-01 – 2012-12-31312000 USD20150305Open filing evidence
2012-07-01 – 2012-09-3063000 USD20131112Open filing evidence
2012-01-01 – 2012-09-30140000 USD20131112Open filing evidence
2012-04-01 – 2012-06-3042000 USD20130829Open filing evidence
2012-01-01 – 2012-06-3077000 USD20130829Open filing evidence
2011-01-01 – 2011-12-3165000 USD20140311Open filing evidence